142 related articles for article (PubMed ID: 32611900)
1. Postoperative Hormonal Outcomes in Patients with Large and Giant Non-functioning Pituitary Adenomas.
Baldia M; Rajaratnam S; Rajshekhar V
Neurol India; 2020; 68(Supplement):S106-S112. PubMed ID: 32611900
[TBL] [Abstract][Full Text] [Related]
2. Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery.
Hwang JY; Aum DJ; Chicoine MR; Dacey RG; Osbun JW; Rich KM; Zipfel GJ; Klatt-Cromwell CN; McJunkin JL; Pipkorn P; Schneider JS; Silverstein JM; Kim AH
Pituitary; 2020 Aug; 23(4):389-399. PubMed ID: 32388803
[TBL] [Abstract][Full Text] [Related]
3. Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
Lee MH; Hur KY; Hong SD; Seol HJ; Choi JW; Lee JI; Nam DH; Kong DS
J Neurooncol; 2021 Jun; 153(2):343-350. PubMed ID: 34002303
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
5. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
6. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A; Wagner JR; Han SW; Tran MT; Miller LM; Chen R; Tom MW; Ostling LR; Kunwar S; Blevins L; Aghi MK
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[TBL] [Abstract][Full Text] [Related]
7. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
8. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
Arafah BM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
10. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (Adenohypophysis) in Patients Following Surgery for Pituitary Adenoma.
Wang S; Ding C; Xiao D; Wu Z; Wei L
Med Sci Monit; 2018 Nov; 24():7944-7951. PubMed ID: 30397189
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
[TBL] [Abstract][Full Text] [Related]
13. The hormonal profile of hypophysial adenomas demonstrates the existence of the secretory interdependence of the pituitary cells.
Fonseca ME; Morán C; Zárate A; Loyo M
Arch Invest Med (Mex); 1984; 15(4):317-30. PubMed ID: 6100161
[No Abstract] [Full Text] [Related]
14. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
15. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors.
Ratnasingam J; Karim N; Paramasivam SS; Ibrahim L; Lim LL; Tan AT; Vethakkan SR; Jalaludin A; Chan SP
Pituitary; 2015 Aug; 18(4):448-55. PubMed ID: 25134488
[TBL] [Abstract][Full Text] [Related]
18. Pathology of pituitary adenomas.
Kovacs K; Horvath E
Bull Los Angeles Neurol Soc; 1977; 42(3-4):92-110. PubMed ID: 227505
[TBL] [Abstract][Full Text] [Related]
19. [Endocrinological analysis of pituitary adenomas associated with hyperprolactinemia (author's transl)].
Sato O; Hotta H; Nakagawa T; Sohma F; Hasunuma M; Tsuchita H; Tanabe S; Kobayashi K; Inoue Y
No To Shinkei; 1981 Nov; 33(11):1115-23. PubMed ID: 6277351
[No Abstract] [Full Text] [Related]
20. Effects of surgery on testosterone secretion in male patients with pituitary adenomas.
Tominaga A; Uozumi T; Arita K; Kurisu K; Yano T; Hirohata T; Eguchi K; Iida K; Kawamoto H
Endocr J; 1996 Jun; 43(3):307-12. PubMed ID: 8886625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
